"Medical Complete" UTAS and Light i30 Individual Photometric Chemistry Analyzer (Unsterilized)
Taiwan·Risk Class 1·FUJIFILM Healthcare Manufacturing Corporation Minamiashigara Takematsu Office;; FUJIFILM WAKO PURE CHEMICAL CORPORATION·Registered Oct 01, 2021 – Oct 31, 2025Expired- Analysis ID
- d3d2e1d18789fbe489e3e81e97abb087
- Customs Code
- DHA08401554501
- Manufacturer Country
- Japan
- Authorized Representative
- MEDICARE PRODUCTS INC.
- Intended Use
- Limited to the first level identification range of the "Individual Photometric Chemistry Analyzer for Clinical Use (A.2160)" of the Measures for the Classification and Grading of Medical Devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.2160 Individual Photometric Chemistry Analyzer for Clinical Use
- Import Information
- QMS/QSD;; 委託製造;; 輸入
- Registration Date
- Oct 01, 2021
- Expiry Date
- Oct 31, 2025
Top companies providing products similar to ""Medical Complete" UTAS and Light i30 Individual Photometric Chemistry Analyzer (Unsterilized)"
Recently registered similar products
Access comprehensive regulatory information for "Medical Complete" UTAS and Light i30 Individual Photometric Chemistry Analyzer (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d3d2e1d18789fbe489e3e81e97abb087 and manufactured by FUJIFILM Healthcare Manufacturing Corporation Minamiashigara Takematsu Office;; FUJIFILM WAKO PURE CHEMICAL CORPORATION. The authorized representative in Taiwan is MEDICARE PRODUCTS INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FUJIFILM TECHNO PRODUCTS CO., LTD. TAKEMATSU FACTORY;; FUJIFILM WAKO PURE CHEMICAL CORPORATION, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.